Navigation Links
Lotus Pharmaceuticals, Inc. Announces Resignation of Director Mel Rothberg
Date:4/24/2008

BEIJING, April 24 /Xinhua-PRNewswire-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a pharmaceutical company in the People's Republic of China ("PRC"), today announced the resignation of Mel Rothberg from the Company's board of directors, effective April 21, 2008, for personal reasons.

Mr. Rothberg served as a director since August 2006. Following his resignation, he will continue to serve as independent consultant to the Company, where he will provide advice and counsel on business development issues as they relate to Lotus' corporate governance and pharmaceutical pipeline. Mr. Rothberg has extensive experience in senior management positions with pharmaceutical and medical device companies with operations worldwide.

"In his tenure on our board, Mel Rothberg made an outstanding contribution to Lotus' corporate governance and development," said Dr. Zhongyi Liu, Chairman and Chief Executive Officer of Lotus. "We look forward to working with him in the future as an independent consultant."

Following Mr. Rothberg's departure, Lotus' board is comprised of seven directors, two of whom are independent.

About Lotus Pharmaceuticals, Inc.

Lotus Pharmaceuticals, Inc. ("Lotus") controls and operates Liangfang Pharmaceutical, Ltd. ("Liangfang") and Enzhe Jiashi Pharmaceutical, Ltd. ("Enzhe"), two Chinese pharmaceutical companies located in Beijing (together "Lotus East"). Lotus East is a comprehensive enterprise, which deals in an integration of the production, trade, sales and marketing of pharmaceuticals. The Company possesses some of the most advanced pharmaceutical-production equipment used in China, workshops authenticated by the National GMP, a suite of various medicines produced by Lotus East, and a number of high-tech personnel. Lotus East has business and office facilities of 2,000 square meters, warehouse of 1,000 square meters and operates ten retail pharmacies in the Beijing a
'/>"/>

SOURCE Lotus Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results
2. Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results
3. Lotus Pharmaceuticals Raises $5 Million in Private Placement
4. Lotus Pharmaceuticals, Inc. Implements Environmentally-friendly Cost Saving Strategies
5. Lotus Blossom Consulting Announces E-Book on Infertility Treatment Financing
6. Aida Pharmaceuticals, Inc. Announces Availability of Downloadable Corporate Synopsis on its Website
7. Aida Pharmaceuticals, Inc. Announces New Antibiotic Drug Under Development
8. Bayer HealthCare Pharmaceuticals, Amerinet Extend Contrast Media Agreement
9. Alseres Pharmaceuticals, Inc. Complies With NASDAQ Rule Regarding Recently Filed 10-K
10. Barr Pharmaceuticals, Inc. Executive Bios
11. Alseres Pharmaceuticals, Inc. Raises $5 Million

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Developed by Opticom Data Rese...for self-examination of the eye. , ... 2009 -- FloatScope is a new hand-held device for ...onitor various ocular health conditions such as fl... well as the functioning of the iris., , , FloatSc...
(Date:11/23/2009)...cent metobolomics study by researchers from Virgin...ond found that impaired peroxisomal oxidation of p...th the progression of nonalcoholic fatty liver (NA...study also found significantly higher plasma monou...th NAFL and NASH. Full findings appear in the Dec...
(Date:11/23/2009)... Same Day STD Testing now provi...or all types of STD,s, including Chlamydia, Herpes...all done anonymously. , (...ound on the web at: http://www.samedaystdtesting....ial STD testing, which is now available to accurat...
(Date:11/23/2009)..., ActingSecretaryEncouragesUseofPAPreferredProduct...wire-USNewswire/--ToensurethatyourfamilyhasasafeTh...ussellReddingisurgingresidentstofollowafewbasicfoo...s. ,, "Followingandunderstandingproperfoodhandl...sureyourThanksgivingdinnerissafetoeat,"saidRedding...
(Date:11/23/2009)...ethylation of arsenic compounds appears to cause o...enicity, according to a new study published online...r Institute . , Although biomethylation was once... thought to enhance its toxicity and potentially i...senic biomethylation in oxidative DNA damage in mi...
Breaking Medicine News(10 mins):Health News:FloatScope - A New Device for Self-Viewing Eye Floaters 2Health News:Metobolomics uncovers key indicators of nonalcoholic fatty liver disease 2Health News:100% Anonymous, Confidential and Quick STD Screening Now Available with Same Day STD Testing 2Health News:Pennsylvania Agriculture Department Encourages Proper Food Handling, Offers Safety Tips for Thanksgiving 2
...July 9 As the U.S. Senate,prepares to vote on leg...physicians, the American Medical Association (AMA)... 6331 to preserve seniors, access to care. In,June...st week, Medicare physician payment cuts of 10.6 p...
...a., July 9 The Air Force,Association today urged ...eased payments to Medicare and TRICARE providers.,...te today to end debate,on an effort to prevent Med...A, along with the Military,Coalition and many grou...
...LL Researchers at the University of North Carolin...on drugs that increase the risk of falling for pat...cations on a regular basis. , "Falls are the lead...n greater risk than those who don,t perhaps two t...
...ikely to be heavier if they spend a lot of time on... July 9 (HealthDay News) -- Teen girls who spend ...ee their weight creeping slowly up than adolescent...he researchers accounted for the amount of exercis...
...if., July 9 Tricom Document Management,(Tricom), ...t of legacy and,current documents for a global cli...ata Centers, Inc. (PDC), a data processing bureau ...test technological advances and,state-of-the-art s...
...to vote soon on legislation that would cut $39 mil...i, WASHINGTON, July 9 Seniors across,Mississippi...icare,Advantage program in legislation being consi...back the areas where Medicare,private fee-for-serv...
Other Medicine News:Health News:Some drugs increase risk of falling: UNC researchers 2Health News:Surfing to a Higher Weight 2Health News:Surfing to a Higher Weight 3Health News:Tricom Document Management Expands Onshore Services with Acquisition of Pacific Data Centers, Inc. 2Health News:Mississippi Seniors Speak Out Against Medicare Advantage Cuts 2
(Date:11/23/2009)...OLNSHIRE,Ill.,Nov.23/PRNewswire/--Sarnova,Inc.,the...ductsintheemergencymedicalservices(EMS)andrespirat...cutivestoitsseniormanagementteam.Thenewexecutivesi...Hill,executivevicepresidentandgeneralcounsel;Steve...itaille,executivevicepresidentofcorporatedevelopme...
(Date:11/23/2009)...ANAPOLIS,Nov.23/PRNewswire/--AMDLASERSannouncedthi...leducationbypartneringwithprestigiousindustry-lead...yAMDLASERS,willbetheexclusivesofttissuediodelaseru...charetargetedtothetop2%ofdentists. ,, (Photo: h...9 ) ,, "ItiswithgreatpleasurethatIproudlyannoun...
(Date:11/23/2009)...CETON,N.J.,Nov.23/PRNewswire-FirstCall/--Pharmasse...ntofCohort2,ledbyitspartnerRoche(SWX:ROG.VX;RO.S,O...1and4patientsintheongoingphase2btrialofRG7128,afir...hetreatmentofchronichepatitisCvirus(HCV)infection....pendentDataMonitoringCommittee(DMC)ofallavailables...
Breaking Medicine Technology:Sarnova Expands Senior Management Team 2AMD LASERS Announces New Partnership with Dr. Larry Rosenthal and Aesthetic Advantage 2Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 2Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 3Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 4IPRO Secures Special NY Funding to Coordinate Care for Patients with Diabetes 58764 1IPRO Secures Special NY Funding to Coordinate Care for Patients with Diabetes 58764 2Massachusetts General Hospital Selects Elekta As New Vendor for Complete Cancer Treatment Solution 5191 1Massachusetts General Hospital Selects Elekta As New Vendor for Complete Cancer Treatment Solution 5191 2Caraco Pharmaceutical Laboratories Ltd Closes Asset Purchase Agreement with Forest Laboratories Inc to Settle Lexapro 28R 29 28escitalopram oxala 5189 1Caraco Pharmaceutical Laboratories Ltd Closes Asset Purchase Agreement with Forest Laboratories Inc to Settle Lexapro 28R 29 28escitalopram oxala 5189 2
...Void in the Local Treatment of Oral Candidiasis in...SBORO, N.J., Dec. 5 RHEI Pharmaceuticals, Inc. to...bozole, a locally active antifungal with low dose ...been initiated in China. This will be the last cl...rug Application (NDA) to the State Food and Drug A...
...c. 4 Long-term data published in,EuroIntervention...Area (MVA),after repair with the MitraClip(R) syst...ociated with clinically significant mitral stenosi...of the patients treated with the,MitraClip(R) syst...ths no,important differences were reported between...
Other Medicine Technology:RHEI Pharmaceuticals Announces the Initiation of the Final Clinical Study for Approval of Tibozole in China 2Two-Year Follow-Up Data Demonstrates Preservation of Adequate Mitral Valve Area in Patients Treated with the MitraClip(R) System 2Two-Year Follow-Up Data Demonstrates Preservation of Adequate Mitral Valve Area in Patients Treated with the MitraClip(R) System 3Two-Year Follow-Up Data Demonstrates Preservation of Adequate Mitral Valve Area in Patients Treated with the MitraClip(R) System 4
...pping System combines the legendary accuracy of th... software. It integrates seamlessly into your EP ...e your clinical capabilities in an easy-to-upgrade...he intended use of the CARTO XP System is catheter...
Model 3077 Single-Chamber Temporary Pacemaker
...'s broadest line of endocardial temporary pacing c...able in both torque control and flow-directed mode...ode spacing options. The Pacel Bipolar Pacing Cat...us right ventricular pacing. Prophylactic system...
Novacor LVAS
Medicine Products: